Chemoinformaics analysis of Ingenol triacetate
Molecular Weight | 474.55 | nRot | 4 |
Heavy Atom Molecular Weight | 440.278 | nRig | 22 |
Exact Molecular Weight | 474.225 | nRing | 4 |
Solubility: LogS | -3.838 | nHRing | 0 |
Solubility: LogP | 2.849 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 72.507 |
nHD | 1 | BPOL | 42.789 |
QED | 0.375 |
Synth | 6.121 |
Natural Product Likeliness | 2.716 |
NR-PPAR-gamma | 0.431 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.989 |
Pgp-sub | 0.342 |
HIA | 0.557 |
CACO-2 | -5.021 |
MDCK | 0.0000549 |
BBB | 0.876 |
PPB | 0.501033 |
VDSS | 1.302 |
FU | 0.456799 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.059 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.633 |
CYP2c9-inh | 0.099 |
CYP2c9-sub | 0.055 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.08 |
CYP3a4-inh | 0.478 |
CYP3a4-sub | 0.673 |
CL | 3.6 |
T12 | 0.058 |
hERG | 0.001 |
Ames | 0.31 |
ROA | 0.974 |
SkinSen | 0.146 |
Carcinogencity | 0.609 |
EI | 0.038 |
Respiratory | 0.965 |
NR-Aromatase | 0.33 |
Antiviral | Yes |
Prediction | 0.742833 |